Document is current
Any future updates will be listed below
-
Authors
Becher, Peter Moritz https://orcid.org/0000-0003-1221-7015
Brunner, Fabian J.
Weimann, Jessica
Remmel, Marko
Schrage, Benedikt
Patten, Monica
Detter, Christian
Reichenspurner, Hermann
Kirchhof, Paulus
Blankenberg, Stefan
Seiffert, Moritz
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 19 April 2025
Accepted: 23 September 2025
First Online: 9 October 2025
Declarations
:
: PMB Becher reports personal fees from AstraZeneca, Ingelheim Boehringer and the German Research Foundation. All outside the submitted work. FJB reports grants from Daiichi Sankyo, Novartis, Pfizer, and Sanofi, non-financial support from ASAHI INTECC, and Inari Medical, personal fees from Amgen, Daiichi Sankyo, Inari Medical, Novartis, and Shockwave. All outside of the submitted work. BS received speaker fee from Abbot, Abiomed, AstraZeneca and Inari as well as research funding from Abiomed. All outside the submitted work. MP reports research grants from Takeda/Shire and personal fees from Alnylam, Amicus, Astra Zeneca, Bristol-Myers Squibb, Cytokinetics, Pfizer, Sanofi/Genzyme, Takeda/Shire. PK received research support for basic, translational, and clinical research projects from European Union, British Heart Foundation, Leducq Foundation, Medical Research Council (UK), and German Center for Cardiovascular Research, from several drug and device companies active in atrial fibrillation and has received honoraria from several such companies in the past, but not in the last three years. Dr. Kirchhof is listed as inventor on two issued patents held by University of Hamburg (Atrial Fibrillation Therapy WO 2015140571, Markers for Atrial Fibrillation WO 2016012783). All outside the submitted work. SB reports grants and personal fees from Abbott Diagnostics, Bayer, Siemens, and Thermo Fisher; grants from Singulex; and personal fees from Abbott, AstraZeneca, Amgen, Medtronic, Pfizer, Roche, Siemens Diagnostics, and Novartis, all outside of the submitted work. MS reports personal fees and non-financial support from Abbott Vascular, personal fees from Abiomed, personal fees from AstraZeneca, grants, personal fees and non-financial support from Boston Scientific, personal fees from Bristol-Myers Squibb, personal fees and non-financial support from Edwards Lifesciences, grants and personal fees from Philips, personal fees from Medtronic, personal fees from Amgen, personal fees from Shockwave Medical, personal fees from Daichii Sankyo, personal fees from Pfizer, personal fees from Siemens Healthineers, personal fees from Inari Medical. All outside the submitted work.
